Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

DIADEM

Financiado

Cerrado

Low Cost Diagnostics Monitoring Technology

Convenience of measuring blood values without need of going to hospital has driven the market in developing several point-of-care blood testing products, which improve patients’ conditions, accessibility to data, and health status... ver más

31/10/2015

BluSense Diagnosti...

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

BLUSENSE DIAGNOSTICS APS No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2015-10-31

PHC-12-2014-1: Clinical research for the validatio...

I+D

Cerrada hace 10 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

BluSense Diagnostics

50.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PoCMICRUX An affordable Multi analyte Point of Care system for Chronic... 71K€ Cerrado

spinitCompanion A point of care device to provide real time blood analysis f... 71K€ Cerrado

MEDMICO Moving to Efficient Diabetes care Multimode Integrated CO m... 4M€ Cerrado

VIRTUALVIALS Virtual vials for enhanced biomolecular analysis 777K€ Cerrado

Rapidemic Rapidemic – A lysis buffer for a novel molecular point-of-ca... 75K€ Cerrado

HG Real time molecular diagnostic testing for human infectious... 71K€ Cerrado

Duración del proyecto: 5 meses Fecha Inicio: 2015-05-19
Fecha Fin: 2015-10-31

Líder del proyecto

BLUSENSE DIAGNOSTICS APS No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Convenience of measuring blood values without need of going to hospital has driven the market in developing several point-of-care blood testing products, which improve patients’ conditions, accessibility to data, and health status awareness (e.g. in diabetes type II monitoring). The biggest challenge that POCT faces is the still low adoption rate by the medical users. Three main adoption barriers nowadays prevent large-scale diffusion of blood-testing POCT in the European market: 1) Equipment Cost: it currently requires around 2 years for paying back the initial investment. The market requires products that can become profitable in much shorter time. 2) Product operability: most of the devices in the market still require manual sample preparation steps, needing trained operators and prone to procedural mistakes, which slow time to result and affect measurement accuracy. 3) Tests availability: Usually POCT devices can measure just very few parameters, forcing users to purchase different machines for different blood tests. Our product, the SenseLab, is designed to provide a simple, reliable and affordable solution for POCT monitoring of diabetes type II–related blood parameters, and beyond. The core of our product is our versatile patented bio-detection technique, the Sense-Ray technology, which allows very precise quantification of multiple biomarkers with extremely simple equipment, built on inexpensive off-the-shelf components. The proposed DIADEM project will provide BluSense management with a very clear landscape of the go-to market approaches which can be taken in the different EU market segments. The objective is to strengthen, via thorough analysis of the individual Europe market segments and geography, the best distribution and cost-structure opportunities for BluSense technology, including tailored regulatory certification pathways. We will be able to prepare a new robust and complete business plan, and to develop a solid commercialization strategy.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores